Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Liang

Showing results (1041-1050 of 1,136) with videos related to

Pageof 114
Sort By:
Haematologica|July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphomaValentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]X H Su, J F Yao, G X Zhang, et al.
JCO Clinical Cancer Informatics|January 14, 2026
Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based ModelsEmily C Liang, Yein Jeon, Yang Qiao, et al.
Ophthalmology|May 21, 2021
The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections, Samir N Patel, Peter H Tang, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2021
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockadeKyle Hansen, Sandeep Kumar, Kathryn Logronio, et al.
Blood Advances|September 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLLEmily C Liang, Aya Albittar, Jennifer J Huang, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
Cell|March 27, 2018
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy PatternsLaura Magill Sack, Teresa Davoli, Mamie Z Li, et al.
Lupus|December 22, 2012
Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanismT-H Yen, H-Y Yang, Y-H Yeh, et al.
Gut|September 21, 2007
Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised studyC-H Liu, C-C Liang, J-W Lin, et al.
Pageof 114

Showing results (1041-1050 of 1,136) with videos related to

Sort By:
Pageof 114
Haematologica|July 2, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphomaValentín Ortiz-Maldonado, Emily C Liang, Jennifer J Huang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 25, 2018
[Allogeneic hematopoietic stem cell transplantation for treatment of refractory and relapsed acute myeloid leukemia: outcomes and prognostic factors]X H Su, J F Yao, G X Zhang, et al.
JCO Clinical Cancer Informatics|January 14, 2026
Time-Series Clustering Captures Patterns of Early Immune Effector Cell-Associated Hematotoxicity That Are Predictable Using Tree-Based ModelsEmily C Liang, Yein Jeon, Yang Qiao, et al.
Ophthalmology|May 21, 2021
The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections, Samir N Patel, Peter H Tang, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2021
COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockadeKyle Hansen, Sandeep Kumar, Kathryn Logronio, et al.
Blood Advances|September 29, 2023
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLLEmily C Liang, Aya Albittar, Jennifer J Huang, et al.
Transplantation and Cellular Therapy|May 18, 2022
Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia in the Modern EraEmily C Liang, Juliana Craig, Stefan Torelli, et al.
Cell|March 27, 2018
Profound Tissue Specificity in Proliferation Control Underlies Cancer Drivers and Aneuploidy PatternsLaura Magill Sack, Teresa Davoli, Mamie Z Li, et al.
Lupus|December 22, 2012
Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanismT-H Yen, H-Y Yang, Y-H Yeh, et al.
Gut|September 21, 2007
Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: a randomised studyC-H Liu, C-C Liang, J-W Lin, et al.
Pageof 114